VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,106,867 | -57.5% | 712,039 | -52.4% | 0.02% | -56.5% |
| Q2 2023 | $44,911,731 | -3.9% | 1,495,274 | +3.1% | 0.05% | -17.9% |
| Q1 2023 | $46,742,590 | +96.7% | 1,449,694 | +74.1% | 0.06% | +107.4% |
| Q4 2022 | $23,765,982 | +4.8% | 832,677 | -11.2% | 0.03% | -27.0% |
| Q3 2022 | $22,672,000 | -25.3% | 937,872 | -14.6% | 0.04% | -11.9% |
| Q2 2022 | $30,354,000 | -14.4% | 1,098,475 | +20.1% | 0.04% | -2.3% |
| Q1 2022 | $35,450,000 | +200.2% | 914,506 | +147.7% | 0.04% | +290.9% |
| Q4 2021 | $11,808,000 | -52.2% | 369,148 | -56.0% | 0.01% | -56.0% |
| Q3 2021 | $24,712,000 | -25.0% | 838,049 | -13.5% | 0.02% | -28.6% |
| Q2 2021 | $32,941,000 | -27.2% | 968,614 | -30.5% | 0.04% | -34.0% |
| Q1 2021 | $45,263,000 | +1218.9% | 1,392,859 | +1360.6% | 0.05% | +960.0% |
| Q4 2020 | $3,432,000 | +43.7% | 95,360 | +56.5% | 0.01% | +25.0% |
| Q3 2020 | $2,388,000 | -86.0% | 60,951 | -91.8% | 0.00% | -90.0% |
| Q1 2020 | $17,046,000 | +10.5% | 739,833 | +40.9% | 0.04% | +48.1% |
| Q4 2019 | $15,425,000 | -61.7% | 524,906 | -65.2% | 0.03% | -64.0% |
| Q3 2019 | $40,254,000 | +0.9% | 1,507,092 | -3.5% | 0.08% | 0.0% |
| Q2 2019 | $39,911,000 | +63.3% | 1,561,484 | +43.3% | 0.08% | +70.5% |
| Q1 2019 | $24,438,000 | -89.1% | 1,090,014 | -89.7% | 0.04% | -89.3% |
| Q4 2018 | $223,770,000 | +85.0% | 10,610,232 | +62.5% | 0.41% | +111.8% |
| Q3 2018 | $120,948,000 | +84.0% | 6,530,646 | +121.7% | 0.20% | +66.7% |
| Q2 2018 | $65,720,000 | -38.4% | 2,945,727 | -39.3% | 0.12% | -26.4% |
| Q1 2018 | $106,753,000 | +110.9% | 4,856,835 | +122.9% | 0.16% | +117.8% |
| Q4 2017 | $50,629,000 | -50.9% | 2,178,549 | -51.5% | 0.07% | -55.8% |
| Q3 2017 | $103,117,000 | +66.3% | 4,491,153 | +59.9% | 0.16% | +44.7% |
| Q2 2017 | $62,020,000 | +380.7% | 2,808,880 | +396.7% | 0.11% | +322.2% |
| Q1 2017 | $12,901,000 | +275.7% | 565,533 | +244.6% | 0.03% | +237.5% |
| Q4 2016 | $3,434,000 | +733.5% | 164,130 | +953.7% | 0.01% | +700.0% |
| Q3 2016 | $412,000 | -91.5% | 15,576 | -91.1% | 0.00% | -92.3% |
| Q2 2016 | $4,855,000 | – | 175,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |